Loading clinical trials...
Loading clinical trials...
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All s...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Skyline Therapeutics
NCT07567898 · Diabetic Macular Edema, Neovascular (Wet) Age-Related Macular Degeneration, and more
NCT05439629 · Neovascular (Wet) Age-related Macular Degeneration
NCT04126317 · Neovascular (Wet) Age-Related Macular Degeneration
NCT04847895 · Neovascular (Wet) Age-related Macular Degeneration
Ophthalmic Consultants of Boston
Boston, Massachusetts
Retina Consultants of Texas
Katy, Texas
Wagner Macula & Retina Center
Norfolk, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions